SCARB1 and atherosclerosis: By reducing the expression of cholesterol transporters SR-B1, ABCA1, and ABCG1, cellular cholesterol efflux from macrophages primed with super-low-dose LPS is suppressed which is associated with elevated foam cell formation in vitro and aggravated atherosclerosis in vivo (27, 71).